Silo Pharma (NASDAQ:SILO) Issues Quarterly Earnings Results

Silo Pharma (NASDAQ:SILO) issued its earnings results on Friday. The company reported ($0.41) earnings per share (EPS) for the quarter, Zacks reports. Silo Pharma had a negative return on equity of 61.38% and a negative net margin of 5,255.05%.

Silo Pharma Stock Down 5.3 %

NASDAQ SILO traded down $0.07 during trading on Friday, reaching $1.25. 71,341 shares of the stock traded hands, compared to its average volume of 3,195,740. Silo Pharma has a fifty-two week low of $0.77 and a fifty-two week high of $4.50. The stock’s 50-day moving average price is $1.52 and its 200 day moving average price is $1.24.

Silo Pharma Company Profile

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.